Number of biotech deals drops as equity balloons


Biotech Quarterly Venture
The number of venture deals in the biotechnology sector continued its downward decline in the first quarter of 2018 compared to the same period in the three previous years. Meanwhile, the amount of equity raised by biotech companies continued to ...

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.

Digital Edition

VCJ_0418-cover

To read a digital copy of our latest magazine

click here